Michael McIntyre

Michael is the Founder, CEO, and co-inventor of LIV Process, the first and only product in the world to provide microbiological visualization of C. diff in history using breakthrough technology that will provide pathways for several derivative applications. Michael has sold, managed, and led 31 new product launches throughout his 38-year career, including 4 product inventions and 5 patents. Michael’s invention submission and patent award for the adhesive gel electrode in 1986 is the standard for ECG procedures in the world. Michael has hybrid experience working with large companies for 2 decades, including Medtronic and J&J, combined with successful start-ups, Advanced Bionics (acquired by Boston Scientific) and Entellus Medical (2015 IPO). Michael graduated from Drexel University with a BS in Marketing and Management and earned his MBA from Michigan State University with a focus on Global Supply Chain and International Leadership.